Virology Specimen Collection Market Statistics Research and Future Growth by 2034

According to Statifacts, the global virology specimen collection market size was valued at USD 1,968 million in 2024 and is expected to reach USD 2,830 million by 2034, growing at a CAGR of 3.7% from 2024 to 2034.

𝐕𝐢𝐞𝐰 𝐃𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐃𝐚𝐭𝐚𝐬𝐞𝐭 (𝐏𝐫𝐢𝐜𝐞: 𝐔𝐒𝐃 1550) ; https://www.statifacts.com/outlook/virology-specimen-collection-market

The virology specimen collection market refers to collecting and transporting samples from a patient to a laboratory for viral testing. The increasing incidences of viral diseases, rising prevalence of human papillomavirus, and increasing blood donations drive the market. The growing demand for laboratory diagnostics and favorable government policies to support virus specimen collection and testing boost market growth. The market is also driven by greater health awareness and disposable incomes. Additionally, the increasing number of clinical trials related to viral diseases requires frequent collection and testing of virology specimens in central reference laboratories, thereby augmenting market growth.

𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐒𝐭𝐮𝐝𝐲 𝐢𝐬 𝐍𝐨𝐰 𝐀𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞 𝐟𝐨𝐫 𝐈𝐦𝐦𝐞𝐝𝐢𝐚𝐭𝐞 𝐀𝐜𝐜𝐞𝐬𝐬 | 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭@ https://www.statifacts.com/download-product/6914
Market Dynamics

Driver: Rising prevalence of viral diseases and emergence of newer pathogens

The Zika virus and Babesia outbreaks, alongside announcements for their inclusion in virology specimen collection tests, indicate the need for innovation in virology specimen collection technologies, consumables, and instruments. Other countries have also undertaken initiatives to check for new and emerging diseases. For example, the prevalence of malaria in African regions and the possibility of mosquito-borne transfer of Zika has resulted in mandates for Zika virus screening in the region.

Opportunity: Emerging economics

Emerging markets such as India, the Middle East, and Africa offer promising opportunities for players in the virology specimen collection industry due to their increasing disposable incomes and improving healthcare infrastructure. For instance, according to Statista (August 2021), India's healthcare sector was worth about USD 160 billion in 2017. It was estimated to reach USD 372 billion by 2022 due to growing income levels, greater health awareness, and the rising incidence of lifestyle diseases. Currently, ELISA is widely used in India, with NAT registering relatively low penetration. NAT is still not mandatory in India, unlike the US, Canada, most of Europe, Japan, Korea, Singapore, Sri Lanka, UAE, South Africa, Thailand, and China. Almost 100 blood banks, including AIIMS, PGI Chandigarh, CMC Vellore, Medanta-The Medicity, and Narayana Hrudayalaya, are using NAT in ID-NAT format, and 40 blood banks are using the pooling technique. Similarly, the Indian government is taking initiatives to train doctors, hospitals, and blood banks to use NAT.

Restraint: Alternative technologies

Various medium solutions have been recommended to stabilize specimens to detect bacteria and viruses, particularly during diagnostic investigations. The future of public health is likely to become increasingly digital, and there is a need for the alignment of international strategies for the regulation, evaluation, and use of digital technologies such as digital epidemiological surveillance, rapid case identification, interruption of community transmission, to strengthen pandemic management, and future preparedness for COVID-19 and other infectious diseases. These are usually based on balanced salt or saline solutions with a buffering capacity to maintain a near-neutral ph. To enhance the stability of viruses, a spectrum of protein supplements has and continues to be recommended. While some laboratories have prepared viral transport medium (VTM) in-house, commercial preparations are used extensively and are often supplied as part of a sample collection kit with sterile swabs.

Challenge: High cost of virology specimen collection technologies

Given the rise in blood donations, blood safety awareness, and healthcare expenditure across the globe, newer technologies are extensively used in high-income countries and will be adopted successfully in middle and lower-income countries in the next decade. However, many developing countries, such as India and China, currently rely on ELISA. This is a major inhibitor for the growth of the virology specimen collection market for NAT in the current timeframe. The high cost of advanced tests has driven the greater use of older, less efficient tests such as first-generation ELISA. Despite its limitations, this test is used in many parts of the world. For instance, the HIV-1 assays from Cepheid and Abbott are estimated to cost USD 17.95 and USD 25.00, respectively. By contrast, a consensus meeting of TB experts suggested that the cost for a replacement test for sputum smear microscopy should be in the range of USD 4-6. Therefore, while it is exciting that new diagnostic tools are becoming available to improve clinical care in austere environments, the cost per test is a key barrier to uptake and sustained use. This presents a need for reducing the prices of virology specimen collection products. Until this challenge is met and overcome, it will continue to hinder the growth of the market.

𝐈𝐦𝐦𝐞𝐝𝐢𝐚𝐭𝐞 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐢𝐬 𝐀𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞 | 𝐆𝐞𝐭 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐀𝐜𝐜𝐞𝐬𝐬@ https://www.statifacts.com/order-report/6914

Impact of AI on the Virology Specimen Collection Market

Artificial Intelligence (AI) is significantly influencing the virology specimen collection market by enhancing diagnostic accuracy, streamlining processes, and improving patient outcomes. As virology gains prominence due to emerging infectious diseases, AI integration has become a catalyst for innovation and efficiency.

1. Improved Diagnostic Accuracy

AI-powered tools are enhancing the precision of virology specimen collection and analysis. Algorithms analyze large datasets to identify optimal collection methods, minimize sample contamination, and detect patterns in viral loads. This ensures accurate diagnostics and supports timely treatment decisions.

2. Optimized Collection Devices

AI is playing a crucial role in designing advanced specimen collection devices. Machine learning algorithms analyze ergonomic and functional requirements to create user-friendly tools that improve sample integrity. For example, AI-driven innovations have led to swabs and containers that enhance viral preservation and transportation efficiency.

3. Automation and Workflow Efficiency

AI-driven automation in specimen collection processes reduces human errors and ensures consistent sample quality. Robotic systems, guided by AI, can perform repetitive tasks such as sorting, labeling, and transporting specimens, accelerating laboratory workflows and minimizing delays in testing.

4. Enhanced Logistics and Supply Chain Management

AI optimizes supply chain operations by predicting demand, tracking inventory, and ensuring timely distribution of specimen collection kits. This is especially critical during outbreaks when demand surges and efficient logistics are essential to maintaining testing capacity.

5. Data Integration and Real-Time Monitoring

AI enables seamless integration of data from virology specimen collection systems with diagnostic platforms. Real-time monitoring of sample quality and storage conditions ensures reliable test results, while AI analytics offer insights into outbreak trends and virus mutations.
Virology Specimen Collection Market Companies:

• Becton
• Dickinson and Company
• Quidel Corporation
• Trinity Biotech
• Titan Biotech
• Diasorin SA
• Vircell S.L.
• Copan Italia S.P.A
• Puritan Medical Products Co.
• Hardy Diagnostics
• Cardinal Health
• Sarstedt
• FL Medical
• Improve Medical

Virology Specimen Collection Market Segmentation:

By Type

• Blood Collection Kits
• Specimen Collection Tubes
• Viral Transport Media
• Swabs

By Application

• Biopharmaceutical Companies
• Academic and Research Institutes

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors

• Provision of market value (USD Million/ Billion) data for each segment and sub-segment

• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

• Includes in-depth analysis of the market from various perspectives through Porter's five forces analysis

• Provides insight into the market through Value Chain

• Market dynamics scenario, along with growth opportunities of the market in the years to come

• 6-month post-sales analyst support
𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐒𝐚𝐥𝐞𝐬 𝐟𝐨𝐫 𝐅𝐮𝐫𝐭𝐡𝐞𝐫 𝐀𝐬𝐬𝐢𝐬𝐭𝐚𝐧𝐜𝐞 𝐢𝐧 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐢𝐧𝐠 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭@ https://www.statifacts.com/order-report/6914
You can place an order or ask any questions, please feel free to contact at sales@statifacts.com| +44 7383 092 044

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:
Ballindamm 22, 20095 Hamburg, Germany
Email: sales@statifacts.com
Europe : +44 7383 092 044

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Statifacts is a leading provider of comprehensive market research and analytics services, offering over 1,000,000 market and customer data sets across various industries. Their platform enables businesses to make informed strategic decisions by providing full access to statistics, downloadable in formats such as XLS, PDF, and PNG.

Visit Our Sitemap: https://www.statifacts.com/outlook/sitemap.xml

This release was published on openPR.